SEC Form 4 · accession 0001127602-16-043511
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 12:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | S | 100 | $70.665 | D | 398,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.68 | D | 398,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.69 | D | 398,534 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.695 | D | 398,434 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $70.72 | D | 398,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.74 | D | 398,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.745 | D | 397,834 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.75 | D | 397,734 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $70.755 | D | 397,434 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.77 | D | 397,334 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.775 | D | 397,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.78 | D | 397,134 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.785 | D | 396,934 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.79 | D | 396,834 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.805 | D | 396,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.81 | D | 396,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.815 | D | 396,534 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.82 | D | 396,434 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $70.83 | D | 396,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.84 | D | 396,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.87 | D | 395,834 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.88 | D | 395,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.89 | D | 395,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.90 | D | 395,534 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.91 | D | 395,434 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.96 | D | 395,334 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.